What we look for in a project
Projects suitable for our portfolio would typically be ready for identification or optimisation of chemical starting points, and meet a number of the following criteria:
-
Aimed at either disease-modifying or symptomatic treatments.
-
Represent emerging or neglected areas rather than those already well supported.
-
Have robust validation of the relevance of the biological pathway to the proposed indication, such as, for example, a genetic link or activity in a suitable in vivo model.
-
Include either assay formats suitable for a high-throughput screen to identify hits, or chemical starting points for optimisation.
-
Carry potential for generating novel intellectual property.
-
Generally possess a profile similar to projects that a private biotech would pursue.
If you have a project that is at the drug discovery or clinical development stage, it may be considered for the Parkinson's Virtual Biotech.
If you have a project that fits with our aims and would be interested in learning more about the opportunities for working together, we would be delighted to hear from you.